ArticleAmerican journal of translational research2026
Sacubitril/valsartan plus dapagliflozin improves cardiac function and reduces MACE and rehospitalization in hFrEF: a retrospective study.
Nimin Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.